Advertisement

Purpose:

Regular risk evaluation and risk monitoring during stone therapy are recommended measures to ensure reduction of recurrence of crystal formation. This strategy optimizes the patient treatment by a more individual approach and decreases expensive over treatment. We evaluated the BONN Risk Index (BRI) through data actualization and evaluation refinement. The BRI was compared with the most common methods of risk evaluation, namely calculation of relative urinary calcium oxalate (CaOx) supersaturation (RS) and of the urine activity product (AP)CaOx index to estimate the urine AP with respect to CaOx.

Materials and Methods:

A total of 201, 12 and 24-hour urine samples were collected from 95 healthy volunteers and from 106 CaOx stone formers. Crystallization experiments following the BRI method were performed. RS and APCaOx were calculated from urinalysis. Data were indexed and individually grouped into 8 classes, and frequency distributions were plotted. A calculation scheme for the BRI based estimation of the statistical probability of a clinically healthy person being a (still nondetected) CaOx stone former is provided.

Results:

Logarithmically arranged BRI groups from healthy subject and patient data showed Gaussian frequency distributions. Compared with RS and APCaOx BRI allowed optimum distinction between healthy subjects and stone formers. The healthy subject probability of already being a CaOx stone former strongly increased with increasing BRI.

Conclusions:

The BRI for evaluating CaOx crystallization risk allows reliable distinction between healthy subjects and CaOx stone formers. Although RS and APCaOx require much more analytical efforts for determination, their results do not show higher reliability.

References

  • 1 Roget's Thesaurus of English Words and Phrases. Edited by . Harlow, United Kingdom: Longman1987. Google Scholar
  • 2 : Physicochemical aspects of urolithiasis. Kidney Int1978; 13: 344. Google Scholar
  • 3 : A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int1986; 30: 85. Google Scholar
  • 4 : Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med1976; 294: 249. Google Scholar
  • 5 : Risk factors in calcium stone disease of the urinary tract. Br J Urol1978; 50: 449. Google Scholar
  • 6 : EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol1985; 134: 1242. LinkGoogle Scholar
  • 7 : Risk formulas in calcium oxalate urolithiasis. World J Urol1997; 15: 176. Google Scholar
  • 8 : A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urines. Urol Res2000; 28: 274. Google Scholar
  • 9 : Determination of urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL applied to a family. J Chem Inf Comput Sci2002; 42: 633. Google Scholar
  • 10 : Testing the predictability of the relative urinary supersaturation from the BONN-Risk-Index for calcium oxalate stone formation. Clin Chem Lab Med2001; 39: 966. Google Scholar
  • 11 : Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med2002; 40: 595. Google Scholar
  • 12 : Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation. Int J Urol1996; 3: 356. Google Scholar
  • 13 : Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res1982; 10: 161. Google Scholar
  • 14 : Epidemiologische Studien zur Inzidenz, Prävalenz und Mortalität des Harnsteinleidens in der Bundesrepublik Deutschland 1979 und 1984. Fortschr Urol Nephrol1987; 25: 1. Google Scholar
  • 15 : Prevalence and incidence of renal stone disease in a German population sample. Klin Wochenschr1981; 59: 411. Google Scholar
  • 16 : Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol2003; 44: 709. Google Scholar
  • 17 : 70,000 Urinary stone analyses—analytical and metaphylactic aspects. In: Urolithiasis. Edited by . Dallas: Millet The Printer, Inc.1996: 452. Google Scholar
  • 18 : A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol2002; 167: 1607. LinkGoogle Scholar
  • 19 : Urinary calculi in aviation pilots: what is the best therapeutic approach?. J Urol2002; 168: 1341. LinkGoogle Scholar
  • 20 : Role of diet in the therapy of urolithiasis. Urol Clin North Am2000; 27: 255. Google Scholar

From the Division of Experimental Urology, Department of Urology (NL, MS, AH) and Geodynamics and Physics of the Lithosphere (SH), University of Bonn, Bonn and Division of Pediatric Nephrology, University Children’s Hospital (BH), Cologne, Germany

Advertisement